@article{ATM20373,
author = {Maria Cristina Dechecchi and Anna Tamanini and Giulio Cabrini},
title = {Molecular basis of cystic fibrosis: from bench to bedside},
journal = {Annals of Translational Medicine},
volume = {6},
number = {17},
year = {2018},
keywords = {},
abstract = {Cystic fibrosis (CF), is an autosomal recessive disease affecting different organs. The lung disease, characterized by recurrent and chronic bacterial infection and inflammation since infancy, is the main cause of morbidity and precocious mortality of these individuals. The innovative therapies directed to repair the defective CF gene should account for the presence of more than 200 disease-causing mutations of the CF transmembrane conductance regulator (CFTR) gene. The review will recall the different experimental approaches in discovering CFTR protein targeted molecules, such as the high throughput screening on chemical libraries to discover correctors and potentiators of CFTR protein, dual-acting compounds, read-through molecules, splicing defects repairing tools, CFTR “amplifiers”.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/20373}
}